RAVINDER SINGH: Open Payments
NPI 1184648990 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,185 in 30 payments from 10 companies in 2025. Trend: 2023 $1,417 · 2024 $9,999 · 2025 $7,185
Speaker / faculty: $5,930Food & beverage: $655Consulting: $490Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $6,744 |
| Lundbeck LLC | 4 | $95 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| ABBVIE INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Genentech USA, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: AUSTEDO XR, VYEPTI, Symbravo, REXULTI, UBRELVY, QULIPTA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Quviviq.
Industry payments across CA — which companies pay providers there.
